Literature DB >> 1967254

Identification of an isozymic form of acetyl-CoA carboxylase.

A Bianchi1, J L Evans, A J Iverson, A C Nordlund, T D Watts, L A Witters.   

Abstract

Acetyl-CoA carboxylase (ACC) is a major rate-limiting enzyme of fatty acid biosynthesis; its product, malonyl-CoA, also contributes to the regulation of fatty acid oxidation and elongation. Using monospecific antibodies directed against rat liver ACC and N- and C-terminal antipeptide antibodies raised against predicted sequences of the cloned ACC of Mr 265,000, we have identified a unique biotin-containing cytosolic protein of molecular mass 280,000 daltons that is distinct from this 265,000-dalton protein. This protein is uniquely expressed in rat cardiac and skeletal muscle but is co-expressed with the 265,000-dalton protein in rat liver, mammary gland, and brown adipose tissue. In the fed rat, white adipose tissue contains only the 265,000-dalton protein. Like the 265,000-dalton protein, the 280,000-dalton protein is present predominantly in the cytosolic fraction of liver. In the liver, the content of both proteins is diminished on fasting and increases on fasting/refeeding with a high carbohydrate diet. In contrast, the cardiac and skeletal muscle 280,000-dalton protein content is unaltered by nutritional manipulation. Avidin-Sepharose isolates of citrate-dependent ACC from the heart reveal only the 280,000-dalton protein, while white adipose tissue isolates show only the 265,000 form. These species differ in the sensitivity to citrate activation and in the Km for acetyl-CoA. Antibodies reactive with the 280,000-dalton protein on immunoblotting precipitate ACC activity in heart isolates, while white adipose ACC is precipitated only by antibodies specific for the 265,000-dalton species. However, in ACC isolates where both proteins are present, a heteroisozyme complex can be detected both by immunoprecipitation and by a sandwich enzyme-linked immunosorbent assay. We conclude that the 280,000-dalton protein is an isozyme of ACC, distinct from the previously cloned 265,000-dalton species. Its presence in cardiac and skeletal muscle, where fatty acid synthesis rates are low, suggest that it might play alternative roles in these tissues such as regulation of fatty acid oxidation or microsomal fatty acid elongation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967254

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

2.  Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis.

Authors:  Chai-Wan Kim; Young-Ah Moon; Sahng Wook Park; Dong Cheng; Hyock Joo Kwon; Jay D Horton
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 3.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  The human ACC2 CT-domain C-terminus is required for full functionality and has a novel twist.

Authors:  Kevin P Madauss; William A Burkhart; Thomas G Consler; David J Cowan; William K Gottschalk; Aaron B Miller; Steven A Short; Thuy B Tran; Shawn P Williams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-04-18

5.  Immunological analysis of acetyl-CoA carboxylase mass, tissue distribution and subunit composition.

Authors:  A J Iverson; A Bianchi; A C Nordlund; L A Witters
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

6.  Alterations in nutritional status regulate acetyl-CoA carboxylase expression in avian liver by a transcriptional mechanism.

Authors:  F B Hillgartner; T Charron; K A Chesnut
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

7.  Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy.

Authors:  Rui Guo; Xihui Xu; Sara A Babcock; Yingmei Zhang; Jun Ren
Journal:  J Hepatol       Date:  2014-10-20       Impact factor: 25.083

8.  Characterization of Maize Acetyl-Coenzyme A Carboxylase.

Authors:  M. A. Egli; B. G. Gengenbach; J. W. Gronwald; D. A. Somers; D. L. Wyse
Journal:  Plant Physiol       Date:  1993-02       Impact factor: 8.340

9.  Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.

Authors:  Geraldine Harriman; Jeremy Greenwood; Sathesh Bhat; Xinyi Huang; Ruiying Wang; Debamita Paul; Liang Tong; Asish K Saha; William F Westlin; Rosana Kapeller; H James Harwood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

10.  ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected].

Authors:  John C Castle; Yoshikazu Hara; Christopher K Raymond; Philip Garrett-Engele; Kenji Ohwaki; Zhengyan Kan; Jun Kusunoki; Jason M Johnson
Journal:  PLoS One       Date:  2009-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.